Abstract
In recent years, a great deal has been learnt about the molecular regulation of kidney development. While most research has focused on the molecular regulation of ureteric branching morphogenesis and nephron formation, significant insights into the definition and functions of the renal stroma have emerged. Many molecules expressed in the developing renal stroma are now known to play significant regulatory roles in kidney development. However, the term ‘renal stroma’ continues to have different meanings to different researchers. This review clarifies this situation and defines the derivation, location and functions of the stroma in the developing metanephros.
Journal Section:
Minireview
References
1.
Clark AT, Bertram JF: Molecular regulation of nephron endowment. Am J Physiol Renal Physiol 1999;276 (pt 2):F485–497.
2.
Clark AT, Bertram JF: Advances in renal development. Curr Opin Nephrol Hypertens 2000;9:247–251.
3.
Burrow CR: Regulatory molecules in kidney development. Pediatr Nephrol 2000;14:240–253.
4.
Kuure S, Vuolteenaho R, Vainio S: Kidney morphogenesis: Cellular and molecular regulation. Mech Dev 2000;92:31–45.
5.
Pohl M, Stuart RO, Sakurai H, Nigam SK: Branching morphogenesis during kidney development. Annu Rev Physiol 2000;62:595–620.
6.
Davies JA, Fisher CE: Genes and proteins in renal development. Exp Nephrol 2002;10:102–113.
7.
Bard JB: Growth and death in the developing mammalian kidney: Signals, receptors and conversations. Bioessays 2002;24:72–82.
8.
Larsen WJ: Human Embryology. New York, Churchill Livingstone, 1993.
9.
Sariola H: Fates of the metanephric mesenchyme; in Vice P, Woolf A, Bard J (eds): The Kidney: From Normal Development to Congenital Disease. London, Academic Press, 2003, pp 181–193.
10.
Grobstein C: Inductive interaction in the development of the mouse metanephros. J Exp Zool 1955;130:319–340.
11.
Grobstein C: Mechanisms of organogenetic tissue interaction. Natl Cancer Inst Monogr 1967;26:107–119.
12.
Ekblom P, Weller A: Ontogeny of tubulointerstitial cells. Kidney Int 1991;39:394–400.
[PubMed]
13.
Al-Awqati Q, Oliver JA: Stem cells in the kidney. Kidney Int 2002;61:387–395.
14.
Bard JB: The metanephros; in Vice P, Woolf A, Bard J (eds): The Kidney: From Normal Development to Congenital Disease. London, Academic Press, 2003, pp 181–193.
15.
Sariola H, Holm K, Henke-Fahle S: Early innervation of the metanephric kidney. Development. 1988;104:589–599.
[PubMed]
16.
Sainio K, Nonclercq D, Saarma M, Palgi J, Saxen L, Sariola H: Neuronal characteristics in embryonic renal stroma. Int J Dev Biol 1994;38:77–84.
[PubMed]
17.
Sariola H, Aufderheide E, Bernhard H, Henke-Fahle S, Dippold W, Ekblom P: Antibodies to cell surface ganglioside GD3 perturb inductive epithelial-mesenchymal interactions. Cell 1988;54:235–245.
18.
Le Douarin NM, Teillet MA: Experimental analysis of the migration and differentiation of neuroblasts of the autonomic nervous system and of neurectodermal mesenchymal derivatives, using a biological cell marking technique. Dev Biol 1974;41:162–184.
19.
Bronner-Fraser M, Fraser SE: Cell lineage analysis reveals multipotency of some avian neural crest cells. Nature 1988;335:161–164.
20.
Hatini V, Huh SO, Herzlinger D, Soares VC, Lai E: Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of winged helix transcription factor BF-2. Genes Dev 1996;10:1467–1478.
[PubMed]
21.
Alcorn D, Maric C, McCausland J: Development of the renal interstitium. Pediatr Nephrol 1999;13:347–354.
22.
Kanwar YS, Carone FA, Kumar A, Wada J, Ota K, Wallner EI: Role of extracellular matrix, growth factors and proto-oncogenes in metanephric development. Kidney Int 1997;52:589–606.
[PubMed]
23.
Maric C, Ryan GB, Alcorn D: Embryonic and postnatal development of the rat renal interstitium. Anat Embryol (Berl) 1997;195:503–514.
24.
Marxer-Meier A, Hegyi I, Loffing J, Kaissling B: Postnatal maturation of renal cortical peritubular fibroblasts in the rat. Anat Embryol (Berl) 1998;197:143–153.
25.
Mendelsohn C, Batourina E, Fung S, Gilbert T, Dodd J: Stromal cells mediate retinoid-dependent functions essential for renal development. Development 1999;126:1139–1148.
[PubMed]
26.
Pfaller W: Structure function correlation on rat kidney. Quantitative correlation of structure and function in the normal and injured rat kidney. Adv Anat Embryol Cell Biol 1982;70:1–106.
[PubMed]
27.
Tisher C, Madsen KM: Anatomy of the kidney; in Brenner & Rector’s The Kidney, ed 6. London, Saunders, 1999.
28.
Lemley KV, Kriz W: Anatomy of the renal interstitium. Kidney Int 1991;39:370–381.
[PubMed]
29.
Klein G, Ekblom P: Extracellular matrix composition during kidney development. Contrib Nephrol 1990;80:17–31.
[PubMed]
30.
Furness PN: Extracellular matrix and the kidney. J Clin Pathol 1996;49:355–359.
[PubMed]
31.
Batourina E, Gim S, Bello N, Shy M, Clagett-Dame M, Srinivas S, Costantini F, Mendelsohn C: Vitamin A controls epithelial/mesenchymal interactions through Ret expression. Nat Genet 2001;27:74–78.
[PubMed]
32.
Li E, Sucov HM, Lee KF, Evans RM, Jaenisch R: Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. Proc Natl Acad Sci USA 1993;90:1590–1594.
[PubMed]
33.
Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub MP, Lemeur M, Chambon P: High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci USA 1993;90:7225–7229.
[PubMed]
34.
Mendelsohn C, Mark M, Dolle P, Dierich A, Gaub MP, Krust A, Lampron C, Chambon P: Retinoic acid receptor beta 2 (RAR beta 2) null mutant mice appear normal. Dev Biol 1994;166:246–258.
[PubMed]
35.
Ghyselinck NB, Dupe V, Dierich A, Messaddeq N, Garnier JM, Rochette-Egly C, Chambon P, Mark M: Role of the retinoic acid receptor beta (RAR beta) during mouse development. Int J Dev Biol 1997;41:425–447.
[PubMed]
36.
Qiao J, Uzzo R, Obara-Ishihara T, Degenstein L, Fuchs E, Herzlinger D: FGF-7 modulates ureteric bud growth and nephron number in the developing kidney. Development 1999;126:547–554.
[PubMed]
37.
Mason IJ, Fuller-Pace F, Smith R, Dickson C: FGF-7 keratinocyte growth factor. Expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial mesenchymal interactions. Mech Dev 1994;45:15–30.
38.
Finch PW, Cunha GR, Rubin JS, Wong J, Ron D: Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn 1995;203:223–240.
[PubMed]
39.
Cancilla B, Ford-Perriss MD, Bertram JF: Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney. Kidney Int 1999;56:2025–2039.
40.
Raatikainen-Ahokas A, Hytonen M, Tenhunen A, Sainio K, Sariola H: Bmp-4 affects the differentiation of metanephric mesenchyme and reveals an early anterior-posterior axis of the embryonic kidney. Dev Dyn 2000;217:146–158.
41.
Schnabel CA, Selleri L, Cleary ML: Pbx1 is essential for adrenal development and urogenital differentiation. Genesis 2003;37:123–130.
42.
Quaggin SE, Schwartz L, Cui S, Igarashi P, Deimling J, Post M, Rossant J: The basic-helix-loop-helix protein Pod1 is critically important for kidney and lung organogenesis. Development 1999;126:5771–5783.
[PubMed]
43.
Cui S, Schwartz L, Quaggin SE: Pod1 is required in stromal cells for glomerulogenesis. Dev Dyn 2003;226:512–522.
44.
Yang J, Blum A, Novak T, Levinson R, Lai E, Barasch J: An epithelial precursor is regulated by the ureteric bud and by the renal stroma. Dev Biol 2002;246:296–310.
45.
Barasch J, Yang J, Ware CB, Taga T, Yoshida K, Erdjument-Bromage H, Tempst P, Parravicini E, Malach S, Aranoff T, Oliver JA: Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell 1999;99:377–386.
46.
Lyons KM, Hogan BLM, Robertson EJ: Colocalization of Bmp 7 and Bmp 2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development. Mech Dev 1995;50:71–83.
47.
Vukicevic S, Kopp JB, Luyten FP, Sampath TK: Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc Natl Acad Sci USA 1996;93:9021–9026.
48.
Godin RE, Takaesu NT, Robertson EJ, Dudley AT: Regulation of BMP7 expression during kidney development. Development 1998;125:3473–3482.
[PubMed]
49.
Weller A, Sorokin L, Illgen EM, Ekblom P: Development and growth of mouse embryonic kidney in organ culture and modulation of development by soluble growth factor. Dev Biol 1991;144:248–261.
50.
Nexo E, Kryger-Baggesen N: The receptor for epidermal growth factor is present in human fetal kidney, liver and lung. Regul Pept 1989;26:1–8.
51.
Perheentupa J, Laksmanahan J, Fisher DA: Urine and kidney epidermal growth factor: Ontogeny and sex difference in the mouse. Pediatr Res 1985;19:428–432.
[PubMed]
52.
Popliker M, Shatz A, Aviva A, Ullrich A, Schlessinger J, Webb CG: Onset of endogenous synthesis of epidermal growth factor in neonatal mice. Dev Biol 1987;119:38–44.
53.
Rogers SA, Ryan G, Hammerman MR: Metanephric transforming growth factor-alpha is required for renal organogenesis in vitro. Am J Physiol 1992;262 (pt 2):F533–539.
54.
Bernardini N, Bianchi F, Lupetti M, Dolfi A: Immunohistochemical localization of the epidermal growth factor, transforming growth factor alpha, and their receptor in the human mesonephros and metanephros. Dev Dyn 1996;206:231–238.
55.
Fine LG, Norman JT, Ong A: Cell to cell crosstalk in the pathogenesis of renal interstitial fibrosis. Kidney Int 1995;47(suppl 49):S48–50.
56.
Bachmann S, Le Hir M, Eckardt Ku: Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 1993;41:335–341.
[PubMed]
57.
Thomas CJ, Woods RL, Evans RG, Alcorn D, Christy IJ, Anderson WP: Evidence for a renomedullary vasodepressor hormone. Clin Exp Pharmacol Physiol 1996;23:777–785.
[PubMed]
© 2005 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2005
You do not currently have access to this content.
